EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use

Nobuyuki Nakamura, Shintaro Aso, Chizuru Nakagawa, Masahiro Tachibana, Aiko Fujikawa, Kazuna Tsubouchi, Naotaka Gunge, Takeshi Miyazaki, Yu Okabe, Hiroshi Matsuzaki, Hirofumi Matsuoka, Nobuhiro Haga

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.03.062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Nobuyuki Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan. Hauptthemen laut MEDLINE: Hematinics, Prolyl-Hydroxylase Inhibitors, Kidney Transplantation, Anemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HematinicsProlyl-Hydroxylase InhibitorsKidney TransplantationAnemiaRenal Insufficiency, ChronicHumansProlyl HydroxylasesHemoglobinsHypoxiaErythropoiesis

Substanzen

HematinicsProlyl-Hydroxylase InhibitorsProlyl HydroxylasesHemoglobins

Autor:innen und Institutionen

  • Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
  • Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan. Electronic address: nhaga@fukuoka-u.ac.jp.

Zitieren

APA

Nakamura, N., Aso, S., Nakagawa, C., Tachibana, M., Fujikawa, A., Tsubouchi, K., Gunge, N., Miyazaki, T., Okabe, Y., Matsuzaki, H., Matsuoka, H., & Haga, N. (2023). Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.03.062

Vancouver

Nakamura N, Aso S, Nakagawa C, Tachibana M, Fujikawa A, Tsubouchi K, et al. Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.03.062

BibTeX
@article{Nakamura2023,
  author = {Nakamura, Nobuyuki and Aso, Shintaro and Nakagawa, Chizuru and Tachibana, Masahiro and Fujikawa, Aiko and Tsubouchi, Kazuna and Gunge, Naotaka and Miyazaki, Takeshi and Okabe, Yu and Matsuzaki, Hiroshi and Matsuoka, Hirofumi and Haga, Nobuhiro},
  title = {Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.03.062}
}
Kostenlos starten →